MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
208.48%
Quick Ratio
208.48%
Cash Ratio
205.89%
Debt to Asset Ratio
38.78%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accounts payable and accrued exp...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
Cash and cash equivalents
82,681
86,573
Prepaid expenses and other current assets
1,042
1,391
Total current assets
83,723
87,964
Property and equipment, net
20,180
20,403
Total assets
103,903
108,367
Accounts payable and accrued expenses
39,291
39,189
Accrued development expense
361
605
Accrued compensation and benefits
385
246
Other current liabilities
121
75
Total current liabilities
40,158
40,115
Other non-current liabilities
136
111
Total liabilities
40,294
40,226
Common stock, 0.001 par value 120,000,000 shares authorized 48,307,896 shares issued and outstanding at june 30, 2026 and december 31, 2025
48
48
Additional paid-in capital
578,579
574,508
Accumulated deficit
-515,018
-506,415
Total stockholders' equity
63,609
68,141
Total liabilities and stockholders' equity
103,903
108,367
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$82,681K
Prepaid expenses and
other current assets
$1,042K
Total current assets
$83,723K
Property and equipment,
net
$20,180K
Total assets
$103,903K
Total liabilities and
stockholders' equity
$103,903K
Total stockholders'
equity
$63,609K
Total liabilities
$40,294K
Accumulated deficit
-$515,018K
Additional paid-in capital
$578,579K
Total current
liabilities
$40,158K
Other non-current
liabilities
$136K
Common stock, 0.001 par
value 120,000,000...
$48K
Accounts payable and
accrued expenses
$39,291K
Accrued compensation
and benefits
$385K
Accrued development
expense
$361K
Other current
liabilities
$121K
Buy us a coffee
FILANA THERAPEUTICS, INC. (FLNA)
FILANA THERAPEUTICS, INC. (FLNA)